RT @transkriptde: Hervorragende Stimmung beim jährlichen Treffen der Schweizer #Biotechnologie-Szene in #Basel. Neben viel Lob äußerte Unte….

Last chance to register: #SBD2019 is less than a week away. Don't miss the most international Swiss Biotech Day yet & register now for the leading #LifeSciences conference in Switzerland:

Only two weeks left, don’t miss the biggest & most international Swiss Biotech Day yet! Find out who is already participating:

Have you checked out the program for #SBD2019 yet? Have a look here and find out more about tracks & participating companies:

Program complete! Less than a month to go until #SBD2019, and the program has now been finalized! Have you checked out the presenting companies yet? Have a look here:

Partnering for #SBD2019 is now open, join 100+ companies for One-to-One meetings in Basel on May 7 2019. More info and a list of participating companies can be found here:

Stay tuned for Swiss Biotech Day 2019

Swiss Biotech Day is fast approaching! Don’t miss out on meeting up with representatives from 450+ companies from 20+ countries! Register now:

.@KPMG and @SIXgroup will present the track "Funding Biotech Companies" at #SBD2018. Experts will be available for discussions and give first hand insight into hot topics. Register now at

Companies like @KPMG, SIX #Swiss Exchange and #IQVIA have already registered for #SBD2018. Don’t miss out, and join entrepreneurs, investors, researchers, analysts, and political decision makers at Swiss Biotech Day on May 03, 2018:

.@KPMG and @SIXgroup will present the track "Funding Biotech Companies" at #SBD2018. Experts will be available for discussions and give first hand insight into hot topics. Register now at

Companies like @KPMG, SIX #Swiss Exchange and #IQVIA have already registered for #SBD2018. Don’t miss out, and join entrepreneurs, investors, researchers, analysts, and political decision makers at Swiss Biotech Day on May 03, 2018:

Medicon Valley is offering its members a 20% discount on a full registration for Swiss Biotech Day! Register today to receive your discount:

New post: Molecular Partners reports promising initial safety and efficacy data from its ongoing phase 2 study of MP0250 in .

New post: ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-301

New post: EuropaBio statement regarding the re-location of the EMA to Amsterdam

New post: New BEAM Alliance Position Paper calls out worldwide stakeholders to support SME-driven innovation and revive the .

New post: Innosuisse taking shape

New post: ADC Therapeutics to Present New Clinical Data for ADCT-402 and ADCT-301 at the American Society of Hematology 2017.

New post: Appell der Wissenschaft und Wirtschaft zur effektiveren Nutzung der schweizerischen Innovationskraft zur Bekämpfun.